Ipsen in the World Eng Contact us Our Company Our Science Our Responsibility Patients Investors Partnering News Careers HOME - INVESTORS Investors As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas. Contact us Craig Marks Adrien Dupin de Saint-Cyr Vice President, Investor Relations Investor Relations Manager +44 7584 349 193 +33 6 64 26 17 49 CONTACT US YTD 2021 sales update Access to the webcast replay Access the Presentation Ipsen in Brief Ipsen in Brief 2021 Discover Ipsen in two pages; our products and key figures, our objectives and our strategy. Download Registration document 2020 Universal Registration Document This registration document contains forward-looking statements about Ipsen’s targets and forecasts, including the Annual Financial Report. The registration document provides a comprehensive information about the Company its activities, financial information, colleagues and legal information Download Capital Markets Day Access the presentation Access the replay CAPITAL MARKETS DAY Stock information Share price and stock information, benchmark, orders, transactions: find out Ipsen share-related data. Ipsen shares ADR program Shareholding structure Analyst coverage STOCK INFORMATION Research & Development pipeline Ipsen R&D has a valuable pipeline encompassing both lifecycle management of our well-established products, and the development of innovative new molecules. Learn more We are focused on accelerating our sales growth while improving our profitability and cash flow generation, in order to further invest in business development to build an innovative and sustainable pipeline and to maintain the growth momentum of the business. Aymeric Le Chatelier, CFO Financial objectives and outlook a 2021 financial objectives Mid-term financial outlook and capital-allocation strategy FINANCIAL OBJECTIVES Annual Report 2020 Under the overarching theme of Focus. Together. For patients & society, Ipsen will be focusing on four strategic priorities to accelerate our innovation and drive positive impact for patients, employees, shareholders and society – a strategy for the short and long term. Explore our 2020 Digital Annual Report ANNUAL REPORT Our company Our Science Our responsibility Patients Partnering Investors News Center Careers Terms & conditions Data privacy Cookie policy Global Privacy Policy © Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021 Your privacy is important to us By clicking “Accept All” , you agree to the storing of cookies on your device to enhance site navigation, measure site performance and show you personalized advertising. You can manage individual cookies preferences or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third-parties intervening on our website, please consult the Cookies Policy, available in the site footer. Cookies settings Reject all Accept all